|Day Low/High||150.09 / 153.71|
|52 Wk Low/High||111.34 / 167.19|
AmerisourceBergen may be headed for a fresh rally leg after breakout to start the year.
Apple, Energen and McKesson are among the top stock picks of Mizuho's analysts for 2017.
Since the election, big questions remain about investing in hospital and healthcare stocks, and the group will remain volatile according to Mizuho.
Look out below when it comes to margins, as the price wars extend to sneakers, drugs and others.
I continue to believe downside risks far outweigh the risks of a near-term rally.
In a "take no pain, take no prisoners" market, health care stocks languish.
McKesson's disappointing earnings report ignited a selloff in health care stocks, and Jim Cramer says investors are questioning the sector's future.
McKesson is down 10 percent year-to-date due to the heated political debate over drug pricing but the stock is too cheap to ignore.
Here are answers to some of your questions to me this morning. Keep 'em coming at firstname.lastname@example.org and I'll answer some more at around 2 p.m. ET. Q. What is your take on TransDigm Group (TDG)? Do I buy it here or wait until it comes down l...
With ABC near a two-year low despite record profits, it no longer is overvalued like last year.
U.S. futures climbed despite falling crude prices as earnings season continues
Three Action Alerts PLUS holding are set to report results.
This is not a good time to own AmerisourceBergen, LinkedIn or Post Holdings.
The bear charts demonstrate how little stress there was in holding those positions for a long way down.
Health care stocks have been hot of late, but given recent volatility in the market, it's time for a technical check-up.
The stock has been net lower since the beginning of June, but if you are looking for a possible bull and bear play, AmerisourceBergen is a name to watch.
The quarter investors couldn't resist is now making every stock pay.